Exclusion criteria: Studies involving non-breast cancer diagnoses, those lacking TNBC or HER2+ subtypes when relevant for pCR prediction, or those not employing MRI or Ki-67 index for assessment were ruled. This evidence concerns the gene ERBB2 and breast carcinoma.